Company / Debt per Share
Bio-Rad Laboratories Debt per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$41.19
FY2025
5-year range
$39.71 / $41.19
FY2022-FY2025
Trend
+2.2%
vs FY2024
Sector context
#18 of 98
Health Care
What the data says
Bio-Rad Laboratories's debt per share of $41.19 is higher than 82% of companies in the Health Care sector (FY2025). Debt per Share has increased for 3 consecutive years, from $39.71 in FY2022 to $41.19 in FY2025.
Based on SEC 10-K filings.
41.19 in FY2025 with a 3-year CAGR of +1.2%. Top quartile in the Health Care sector.
Increased from $40.06 to $41.19 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- +1.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 98This company $41.19 Sector average $46.19
▼
-10.8% below sector average
Key checks
Key Insights
- Bio-Rad Laboratories's debt per share has grown for 3 consecutive years.
- In FY2025, debt per share increased 2.2% year-over-year.
- Ranks #18 out of 98 companies in the Health Care sector.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $41.19 | +2.2% |
| FY2024 | $40.30 | +0.6% |
| FY2023 | $40.06 | +0.9% |
| FY2022 | $39.71 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026